Indaptus Therapeutics INDP
NASDAQ INDP
$3.16 +0.20 (+6.76%)
At close: Oct 21, 2026 · 4:00 PM EDT

Indaptus Therapeutics (INDP) Current Debt (2025)

Updated

Indaptus Therapeutics (INDP) reported Current Debt of $365,718 for Q3 2025.

Analysis

Indaptus Therapeutics (INDP) Current Debt (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -5.75 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 64.00 Mn
10 Indaptus Therapeutics 200.03 Mn 172.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 365,718.00
API Access

Indaptus Therapeutics Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=INDP&period=max&api_key=YOUR_API_KEY